Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Assembly Biosciences
(NQ:
ASMB
)
4.480
USD
UNCHANGED
Streaming Delayed Price
Updated: 5:43 AM EST, Mar 8, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
426
Open
4.480
Bid (Size)
4.500 (2)
Ask (Size)
4.630 (2)
Prev. Close
4.480
Today's Range
4.480 - 4.500
52wk Range
4.305 - 27.84
Shares Outstanding
20,550,718
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 05, 2021
From
GlobeNewswire News Releases
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of Triple Combination Therapy for the Treatment of Chronic Hepatitis B Virus
February 26, 2021
From
GlobeNewswire News Releases
Performance
YTD
-25.83%
-25.83%
1 Month
-27.15%
-27.15%
3 Month
-26.86%
-26.86%
6 Month
-74.89%
-74.89%
1 Year
-74.44%
-74.44%
More News
Read More
Assembly Biosciences Reports Fourth Quarter and Year End 2020 Financial Results and Recent Highlights
February 25, 2021
From
GlobeNewswire News Releases
Assembly Biosciences Updates Pipeline Strategy, Focusing on Finite and Curative Therapies for Chronic Hepatitis B Virus Infection
February 25, 2021
From
GlobeNewswire News Releases
Assembly Bio Announces Upcoming Investor Events
February 19, 2021
From
GlobeNewswire News Releases
Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 05, 2021
From
GlobeNewswire News Releases
Assembly Biosciences to Wind-Down Microbiome Program
December 08, 2020
From
GlobeNewswire News Releases
Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 04, 2020
From
GlobeNewswire News Releases
Assembly Biosciences Appoints Nicole S. White, PhD, as Senior Vice President of Pharmaceutical Development and Manufacturing
November 17, 2020
From
GlobeNewswire News Releases
Assembly Bio/Arbutus Bio Start Testing Vebicorvir/AB-729 Triplet Therapy In HBV Infection
February 26, 2021
Tags
Biotech
General
ASMB
From
Benzinga
Assembly Biosciences Foregoes Vebicorvir Registration Studies For Chronic Suppressive Therapy
February 26, 2021
Tags
Biotech
Market News
FDA
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.